← Browse by Condition
Medical Condition
iga nephropathy
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 4
NCT05775042 Phase 2
Recruiting
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
Enrollment
70 pts
Location
China
Sponsor
Keymed Biosciences Co.Ltd
NCT07030894 Phase 4
Recruiting
Nefecon and Ambrisentan in IgA Nephropathy
Enrollment
129 pts
Location
China
Sponsor
The First Hospital of Jilin Un...
NCT05434325
Recruiting
TESTING -ON Post-Trial ObservatioNal Cohort Study
Enrollment
366 pts
Location
Australia, Canada, C...
Sponsor
The George Institute
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association